rs773314113
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM2BP6_Very_Strong
The NM_014391.3(ANKRD1):c.346-14_346-9del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000398 in 1,305,016 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00088 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000010 ( 0 hom. )
Consequence
ANKRD1
NM_014391.3 splice_polypyrimidine_tract, intron
NM_014391.3 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.67
Genes affected
ANKRD1 (HGNC:15819): (ankyrin repeat domain 1) The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 10-90918980-CAAAATA-C is Benign according to our data. Variant chr10-90918980-CAAAATA-C is described in ClinVar as [Likely_benign]. Clinvar id is 201657.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-90918980-CAAAATA-C is described in Lovd as [Likely_benign].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD1 | NM_014391.3 | c.346-14_346-9del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000371697.4 | NP_055206.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD1 | ENST00000371697.4 | c.346-14_346-9del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_014391.3 | ENSP00000360762 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000883 AC: 39AN: 44146Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
39
AN:
44146
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000103 AC: 13AN: 1260892Hom.: 0 AF XY: 0.00000789 AC XY: 5AN XY: 633438
GnomAD4 exome
AF:
AC:
13
AN:
1260892
Hom.:
AF XY:
AC XY:
5
AN XY:
633438
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000884 AC: 39AN: 44124Hom.: 0 Cov.: 0 AF XY: 0.000910 AC XY: 19AN XY: 20882
GnomAD4 genome
AF:
AC:
39
AN:
44124
Hom.:
Cov.:
0
AF XY:
AC XY:
19
AN XY:
20882
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 06, 2013 | The variant is found in DCM panel(s). - |
ANKRD1-related dilated cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 21, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at